Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01E
- Chemical subgroupL01EN
- Chemical substanceL01EN03Infigratinib
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 4 registrations
European Union
EMA · 1 registration
United States
FDA · 1 registration
At a glance
- ATC code
- L01EN03
- Registers
- 3
- Registrations
- 6
- With their own page
- 1
- Companies
- 3
All medicines with Infigratinib
Human medicines from every register that match Infigratinib by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
6 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Truseltiq | United States | 100MG, 25MG | capsule | Not marketed | Helsinn Hlthcare |
| Febseltiq | European Union | Refused | Helsinn Birex Pharmaceuticals Ltd | ||
| Truseltiq | Canada | 50 MG / DOSE | Capsule | Cancelled | Qed Therapeutics, INC. |
| Truseltiq | Canada | 125 MG / DOSE | Capsule | Cancelled | Qed Therapeutics, INC. |
| Truseltiq | Canada | 100 MG / DOSE | Capsule | Cancelled | Qed Therapeutics, INC. |
| Truseltiq | Canada | 75 MG / DOSE | Capsule | Cancelled | Qed Therapeutics, INC. |